Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study

被引:3
|
作者
Zeng, Huancheng [1 ]
Qiu, Siqi [2 ,3 ]
Zhuang, Shuxin [4 ]
Wei, Xiaolong [5 ]
Wu, Jundong [1 ]
Zhang, Ranze [6 ]
Chen, Kai [6 ]
Wu, Zhiyong [2 ]
Zhuang, Zhemin [7 ]
机构
[1] Shantou Univ, Canc Hosp, Breast Ctr, Med Coll, Shantou, Peoples R China
[2] Shantou Cent Hosp, Diag & Treatment Ctr Breast Dis, Shantou, Peoples R China
[3] Shantou Cent Hosp, Clin Res Ctr, Shantou, Peoples R China
[4] Sun Yat Sen Univ, Sch Biomed Engn, Shenzhen, Peoples R China
[5] Shantou Univ, Canc Hosp, Pathol Dept, Med Coll, Shantou, Peoples R China
[6] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China
[7] Shantou Univ, Engn Coll, Shantou, Peoples R China
基金
中国国家自然科学基金;
关键词
breast cancer; deep learning; neoadjuvant chemotherapy; pathological complete response; pathological images; THERAPY; WOMEN;
D O I
10.3389/fphys.2024.1279982
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Early predictive pathological complete response (pCR) is beneficial for optimizing neoadjuvant chemotherapy (NAC) strategies for breast cancer. The hematoxylin and eosin (HE)-stained slices of biopsy tissues contain a large amount of information on tumor epithelial cells and stromal. The fusion of pathological image features and clinicopathological features is expected to build a model to predict pCR of NAC in breast cancer.Methods: We retrospectively collected a total of 440 breast cancer patients from three hospitals who underwent NAC. HE-stained slices of biopsy tissues were scanned to form whole-slide images (WSIs), and pathological images of representative regions of interest (ROI) of each WSI were selected at different magnifications. Based on several different deep learning models, we propose a novel feature extraction method on pathological images with different magnifications. Further, fused with clinicopathological features, a multimodal breast cancer NAC pCR prediction model based on a support vector machine (SVM) classifier was developed and validated with two additional validation cohorts (VCs).Results: Through experimental validation of several different deep learning models, we found that the breast cancer pCR prediction model based on the SVM classifier, which uses the VGG16 model for feature extraction of pathological images at x20 magnification, has the best prediction efficacy. The area under the curve (AUC) of deep learning pathological model (DPM) were 0.79, 0.73, and 0.71 for TC, VC1, and VC2, respectively, all of which exceeded 0.70. The AUCs of clinical model (CM), a clinical prediction model established by using clinicopathological features, were 0.79 for TC, 0.73 for VC1, and 0.71 for VC2, respectively. The multimodal deep learning clinicopathological model (DPCM) established by fusing pathological images and clinicopathological features improved the AUC of TC from 0.79 to 0.84. The AUC of VC2 improved from 0.71 to 0.78.Conclusion: Our study reveals that pathological images of HE-stained slices of pre-NAC biopsy tissues can be used to build a pCR prediction model. Combining pathological images and clinicopathological features can further enhance the predictive efficacy of the model.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
    Fengling Li
    Yongquan Yang
    Yani Wei
    Ping He
    Jie Chen
    Zhongxi Zheng
    Hong Bu
    Journal of Translational Medicine, 19
  • [2] Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
    Li, Fengling
    Yang, Yongquan
    Wei, Yani
    He, Ping
    Chen, Jie
    Zheng, Zhongxi
    Bu, Hong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [3] Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer : A multicenter study
    Li, Bao
    Li, Fengling
    Liu, Zhenyu
    Xu, FangPing
    Ye, Guolin
    Li, Wei
    Zhang, Yimin
    Zhu, Teng
    Shao, Lizhi
    Chen, Chi
    Sun, Caixia
    Qiu, Bensheng
    Bu, Hong
    Wang, Kun
    Tian, Jie
    BREAST, 2022, 66 : 183 - 190
  • [4] Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Mamba-Based Deep Learning: A Multicenter Retrospective Study
    Zhang, Wenchuan
    Zhang, Shuwan
    Li, Fengling
    Wu, Xiaoyan
    Lu, Xunxi
    Yi, Yuhao
    Bu, Hong
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [5] Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study
    Qian, Bei
    Yang, Jing
    Zhou, Jun
    Hu, Longqing
    Zhang, Shoupeng
    Ren, Min
    Qu, Xincai
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    CANCER RESEARCH, 2011, 71
  • [7] Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
    Qu, Yu-Hong
    Zhu, Hai-Tao
    Cao, Kun
    Li, Xiao-Ting
    Ye, Meng
    Sun, Ying-Shi
    THORACIC CANCER, 2020, 11 (03) : 651 - 658
  • [8] Occult breast cancer with pathological complete response to neoadjuvant chemotherapy
    Ren, Ningning
    Liu, Shuo
    Shi, Peng
    Tian, Xingsong
    ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4949 - 4951
  • [9] Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques
    Heil, J.
    Kuemmel, S.
    Schaefgen, B.
    Paepke, S.
    Thomssen, C.
    Rauch, G.
    Ataseven, B.
    Grosse, R.
    Dreesmann, V.
    Kuehn, T.
    Loibl, S.
    Blohmer, J. U.
    Minckwitz, G. V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S275 - S276
  • [10] Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques
    Joerg Heil
    Sherko Kümmel
    Benedikt Schaefgen
    Stefan Paepke
    Christoph Thomssen
    Geraldine Rauch
    Beyhan Ataseven
    Regina Große
    Volker Dreesmann
    Thorsten Kühn
    Sibylle Loibl
    Jens-Uwe Blohmer
    Gunter von Minckwitz
    British Journal of Cancer, 2015, 113 : 1565 - 1570